Skip to content
Search

Latest Stories

Study finds over half of pharmacists optimistic about their business in 2021

Over half of country's the pharmacists have positive outlook about their business prospects in 2021, a latest survey showed on Tuesday (Jan 26).

Business property adviser - Christie & Co - in its ‘Business Outlook 2021: Review. Realign. Recover,’ noted that the pharmacy market will remain strong throughout 2021 as the vaccination drive continues to roll out in community pharmacies across the country strengthens the market further.


Over 50 per cent of pharmacists said they are feeling positive about their business recovery this year, with 62.1 per cent feeling that the sector will take less than a year to return to pre-Covid levels.

The study also found that 73 per cent of pharmacists consider that there are opportunities within the sector.

Just over 38 per cent of the pharmacists surveyed said that they are looking to sell their business in 2021, whereas 29 per cent said they are looking to acquire a business or additional pharmacy this year.

“The survey responses underpin the current levels of confidence in the pharmacy sector and evoke optimism in the New Year,” the survey report noted.

When asked to measure the impact that Covid-19 has had on their pharmacy businesses, 36.4 per cent pharmacists said that the pandemic had a positive impact. However, 33.3 per cent of the respondents said that the pandemic adversely impacted their business.

The remaining 24.2 per cent said that the virus has had a low impact, and just 6.1 per cent stated it didn’t impact them at all. “This mix of responses is likely due to pharmacies remaining open and the result of how they adapted to the increasing challenges faced,” the report said.

Tony Evans, head of pharmacy at Christie & Co, said: “After what can only be described as a turbulent year, pharmacy responded well to the challenges the pandemic delivered. In doing so, many were quick to realise not only the important role pharmacy plays in the delivery of primary care, but also the opportunity to extend the services the sector can offer. Our sales activity is testimony to the continued appetite and confidence we have seen and bodes well for a healthy market in 2021.”

Meanwhile, the survey recorded strong levels of buyer interest in the pharmacy sector throughout 2020, both from existing operators looking to expand their activities and first-time buyers still keen to acquire.

This buyers’ interest resulted in a 14 per cent increase in completions and a 9.5 per cent increase in sales agreed compared with 2019, the survey revealed.

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less